Article Text

Download PDFPDF
Statins for the treatment of asthma: a discovery well, dry hole or just snake oil
  1. Bruce K Rubin
  1. Dr Bruce K Rubin, Wake Forest University School of Medicine, Medical Center Blvd, Winston-Salem, North Carolina 27157-1081, USA; brubin{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Until the 1906 Food and Drug Act in the USA, it was common for travelling salesman to move from town to town selling miraculous cures in the form of patent medicines. With the wide spread promotion of Clark Stanley’s Snake Oil Liniment, the term “snake oil” became a widely accepted derogatory phrase for ineffective patent medications sold with claims for curing an extraordinarily variety of illnesses.1

Statins are inhibitors of the 3-hydroxy-3-methylglutaryl coenzymes A (HMG-CoA) reductase. These are among the most widely prescribed medications in the world today. Statins are dramatically effective, treating hyperlipidaemia and preventing cardiovascular disease, particularly in high risk populations.2 Statins have also been shown in the laboratory to have impressive immunomodulatory effects.3 These drugs suppress T helper (Th)1 cell development and promote Th2 polarisation from CD4 cells in vitro.4 Statins act as direct inhibitors of major histocompatibility antigen (MHC) class 2 expression and interferon γ (IFNγ) and thus inhibit T cell activation.5

In animal models, statins can ameliorate Th1 inflammatory disorders such as collagen induced arthritis and are being considered as a promising therapy …

View Full Text


  • Competing interests: None.

Linked Articles